CAPTRUST Financial Advisors
DNA icon

CAPTRUST Financial Advisors’s Ginkgo Bioworks DNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-455
Closed -$6.08K – 2314
2024
Q2 		$6.08K Buy
455
+75
+20% +$2.24K ﹤0.01% 2194
2024
Q1 		$17.6K Sell
380
-1,532
-80% -$79.3K ﹤0.01% 2117
2023
Q4 		$129K Sell
1,912
-296
-13% -$18.1K ﹤0.01% 2493
2023
Q3 		$160K Buy
2,208
+196
+10% +$15.7K ﹤0.01% 2351
2023
Q2 		$150K Buy
2,012
+830
+70% +$49.1K ﹤0.01% 2329
2023
Q1 		$62.9K Buy
+1,182
New +$74.9K ﹤0.01% 2199
2022
Q4 		– Sell
-972
Closed -$121K – 2094
2022
Q3 		$121K Buy
972
+516
+113% +$61.5K ﹤0.01% 1917
2022
Q2 		$43K Buy
456
+48
+12% +$5.85K ﹤0.01% 2863
2022
Q1 		$66K Buy
408
+283
+226% +$55.1K ﹤0.01% 2584
2021
Q4 		$42K Sell
125
-3
-2% -$1.43K ﹤0.01% 2789
2021
Q3 		$59K Buy
+128
New +$62.3K ﹤0.01% 2465

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CAPTRUST Financial Advisors's DNA Position: Q3 2024 in Review

CAPTRUST Financial Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 455 shares — an estimated $6.08K sold.

CAPTRUST Financial Advisors first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $160K in Q3 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • CAPTRUST Financial Advisors reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 455 Ginkgo Bioworks shares in Q3 2024, an estimated $6.08K.
  • CAPTRUST Financial Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Ginkgo Bioworks position peaked at $160K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.